148 related articles for article (PubMed ID: 20668083)
1. Role of the innate immune response and tumor immunity associated with simian virus 40 large tumor antigen.
Lowe DB; Shearer MH; Aldrich JF; Winn RE; Jumper CA; Kennedy RC
J Virol; 2010 Oct; 84(19):10121-30. PubMed ID: 20668083
[TBL] [Abstract][Full Text] [Related]
2. Tumor immunity against a simian virus 40 oncoprotein requires CD8+ T lymphocytes in the effector immune phase.
Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
J Virol; 2010 Jan; 84(2):883-93. PubMed ID: 19889780
[TBL] [Abstract][Full Text] [Related]
3. The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigen.
Aldrich JF; Shearer MH; Lowe DB; Winn RE; Jumper CA; Kennedy RC; Bright RK
Cancer Immunol Immunother; 2013 Feb; 62(2):371-82. PubMed ID: 22926061
[TBL] [Abstract][Full Text] [Related]
4. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
5. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
Bright RK; Shearer MH; Kennedy RC
J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
[TBL] [Abstract][Full Text] [Related]
6. Comparison of simian virus 40 large T antigen recombinant protein and DNA immunization in the induction of protective immunity from experimental pulmonary metastasis.
Watts AM; Shearer MH; Pass HI; Bright RK; Kennedy RC
Cancer Immunol Immunother; 1999 Feb; 47(6):343-51. PubMed ID: 10203065
[TBL] [Abstract][Full Text] [Related]
7. Fc gamma receptors play a dominant role in protective tumor immunity against a virus-encoded tumor-specific antigen in a murine model of experimental pulmonary metastases.
Lowe DB; Shearer MH; Jumper CA; Bright RK; Kennedy RC
J Virol; 2007 Feb; 81(3):1313-8. PubMed ID: 17108042
[TBL] [Abstract][Full Text] [Related]
8. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
9. In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization.
Lowe DB; Shearer MH; Tarbox JA; Kang HS; Jumper CA; Bright RK; Kennedy RC
Virology; 2005 Feb; 332(1):28-37. PubMed ID: 15661138
[TBL] [Abstract][Full Text] [Related]
10. DNA cancer vaccination strategies target SV40 large tumour antigen in a murine experimental metastasis model.
Watts AM; Bright RK; Kennedy RC
Dev Biol (Basel); 2000; 104():143-7. PubMed ID: 11713812
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity of simian virus 40-transformed C57BL/6 mouse embryo fibroblasts to lysis by murine natural killer cells.
Fresa KL; Karjalainen HE; Tevethia SS
J Immunol; 1987 Feb; 138(4):1215-20. PubMed ID: 3027174
[TBL] [Abstract][Full Text] [Related]
12. The level of MHC class I expression on murine adenocarcinoma can change the antitumor effector mechanism of immunocytokine therapy.
Imboden M; Murphy KR; Rakhmilevich AL; Neal ZC; Xiang R; Reisfeld RA; Gillies SD; Sondel PM
Cancer Res; 2001 Feb; 61(4):1500-7. PubMed ID: 11245457
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-induced activation of adaptive and innate antitumor immunity.
van den Broeke LT; Daschbach E; Thomas EK; Andringa G; Berzofsky JA
J Immunol; 2003 Dec; 171(11):5842-52. PubMed ID: 14634094
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-4 impairs granzyme-mediated cytotoxicity of Simian virus 40 large tumor antigen-specific CTL in BALB/c mice.
Baschuk N; Utermöhlen O; Gugel R; Warnecke G; Karow U; Paulsen D; Brombacher F; Krönke M; Deppert W
Cancer Immunol Immunother; 2007 Oct; 56(10):1625-36. PubMed ID: 17431618
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of SV40 induced tumours in mice: a model for vaccine development.
Bright RK; Shearer MH; Pass HI; Kennedy RC
Dev Biol Stand; 1998; 94():341-53. PubMed ID: 9776255
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated expression of interleukin-12 induces natural killer cell activity and complements adenovirus-directed gp75 treatment of melanoma lung metastases.
Hirschowitz EA; Crystal RG
Am J Respir Cell Mol Biol; 1999 May; 20(5):935-41. PubMed ID: 10226063
[TBL] [Abstract][Full Text] [Related]
17. Activation of NK cell cytotoxicity by aerosolized CpG-ODN/poly(I:C) against lung melanoma metastases is mediated by alveolar macrophages.
Sommariva M; Le Noci V; Storti C; Bianchi F; Tagliabue E; Balsari A; Sfondrini L
Cell Immunol; 2017 Mar; 313():52-58. PubMed ID: 28089340
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T lymphocytes are critical mediators of tumor immunity to simian virus 40 large tumor antigen induced by vaccination with plasmid DNA.
Aldrich JF; Lowe DB; Shearer MH; Winn RE; Jumper CA; Bright RK; Kennedy RC
J Virol; 2011 Jul; 85(14):7216-24. PubMed ID: 21593176
[TBL] [Abstract][Full Text] [Related]
19. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
20. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
